表紙
市場調查報告書

Medsuite:韓國的整形外科生醫材料市場 (2020-2026年)

Orthopedic Biomaterials Market Report Suite | South Korea | 2020-2026 | Medsuite

出版商 iData Research Inc. 商品編碼 925594
出版日期 內容資訊 英文 293 Pages
商品交期: 最快1-2個工作天內
價格
Medsuite:韓國的整形外科生醫材料市場 (2020-2026年) Orthopedic Biomaterials Market Report Suite | South Korea | 2020-2026 | Medsuite
出版日期: 2020年03月01日內容資訊: 英文 293 Pages
簡介

2019年的韓國人口的約有15%是65歲以上,這個比例在預測期間內預計踏實增加。該人口成長預計刺激國內整形外科生醫材料市場成長。

本報告提供韓國的整形外科生醫材料的市場調查,市場背景,產品系列,骨移植片,去礦物質骨基質(DBM)移植片,合成骨等的骨移植片替代品,整形外科用生長因子,玻尿酸粘性劑的市場規模的變化、預測,使用這些材料的整形外科治療數量,市場成長的各種影響因素分析,競爭環境,市場佔有率,主要企業簡介等資訊彙整。

產品的評估

  • 簡介
  • 產品系列
  • 法規上的課題、回收
  • 臨床試驗

韓國的整形外科生醫材料市場:市場概要

  • 簡介
    • 移植骨替代物
    • 生長因子
    • 玻尿酸(HA)增稠劑
  • 匯率
  • 市場概要、趨勢分析
  • 成長推動因素、抑制因素
  • 企業佔有率分析
  • M&A
  • 企業簡介
    • Anika Therapeutics
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Pharmaceuticals
    • Genzyme (Sanofi Group)
    • Harvest Technologies (Terumo BCT)
    • Integra LifeSciences
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • NuVasive
    • Orthofix
    • RTI Surgical
    • Stryker
    • Vericel Corporation
    • Zimmer Biomet
  • SWOT分析

手術數量

  • 簡介
  • 手術數量:各類型
    • 骨移植
    • 使用了生長因子的手術
    • 玻尿酸補充

整形外科用移植骨替代物市場

  • 簡介
  • 市場概要
  • 市場分析、預測
    • 整體市場
    • 各材料
    • 各適應症
  • 成長推動因素、抑制因素
  • 企業佔有率分析

整形外科用生長因子市場

  • 簡介
    • BMP-2(Medtronic)
    • PDGF-BB(Wright Medical)
    • P-15合成小肽(Cerapedics)
    • P-15合成小肽(Biocomposites)
  • 成長推動因素、抑制因素
  • 企業佔有率分析

玻尿酸關節內補充市場

  • 簡介
  • 市場概要
  • 市場分析、預測
    • 整體市場
    • 單回注射
    • 3次注射
  • 成長推動因素、抑制因素
  • 企業佔有率分析

簡稱

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_SKOB20_MS

The South Korean orthopedic biomaterials market was valued at $141.6 million in 2019. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $181.5 million.

A lack of product differentiation across similar injection cycle products has led to commoditization, which has stifled innovation and the further development of new products. Similar to Japan, the prices of HA viscosupplementation products in South Korea have drastically decreased since their introduction and are among the lowest in the world.

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 15% of South Koreans were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.

The bone graft substitute market in South Korea is primarily dominated by allografts and DBM allografts. A major driver to their usage is that they are both easily accessible, as they are distributed by several companies and bone banks.

The full report suite on the South Korean market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. This report also includes hyaluronic acid (HA) viscosupplementation.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES VIII

LIST OF CHARTS XV

EXECUTIVE SUMMARY 1

SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 5

MARKET DEVELOPMENTS 6

PROCEDURE NUMBERS 7

MARKETS INCLUDED 8

KEY REPORT UPDATES 10

VERSION HISTORY 10

RESEARCH METHODOLOGY 11

  • Step 1: Project Initiation & Team Selection 11
  • Step 2: Prepare Data Systems and Perform Secondary Research 14
  • Step 3: Preparation for Interviews & Questionnaire Design 16
  • Step 4: Performing Primary Research 17
  • Step 5: Research Analysis: Establishing Baseline Estimates 19
  • Step 6: Market Forecast and Analysis 20
  • Step 7: Identify Strategic Opportunities 22
  • Step 8: Final Review and Market Release 23
  • Step 9: Customer Feedback and Market Monitoring 24

PRODUCT ASSESSMENT 25

  • 2.1 INTRODUCTION 25

TABLE OF CONTENTS

© iData Research Inc., 2020 ii

  • 2.2 PRODUCT PORTFOLIOS 25

Bone Graft Substitutes 26

Growth Factors 32

Other Products 35

Hyaluronic Acid Viscosupplementation (HAV) 37

  • 2.3 REGULATORY ISSUES AND RECALLS 40

Bone Graft Substitutes 40

Allografts 40

MTF 40

DBM 40

AlloSource 40

SeaSpine 41

RTI Surgical 41

Synthetics 41

Abyrx 41

Zimmer Biomet 42

Growth Factors 42

Medtronic 42

Hyaluronic Acid Viscosupplementation 43

Three-injection 43

Ferring Pharmaceuticals 43

  • 2.4 CLINICAL TRIALS 44

Bone Graft Substitutes 44

Allografts 44

Providence Medical Technology 44

The University of Texas Health Science 44

University of Winchester 45

BDM 45

K2M 45

Zimmer Biomet 46

Synthetics 46

Baxter 46

Bonesupport 47

DePuy Synthes 47

NuVasive 49

RTI surgical 49

Sunstar GUIDOR 50

Other materials and comparison 51

Seoul National University Hospital. 51

Sewon Cellontech 51

SurgaColl Technologies Limited 52

University of Colorado 52

University of Padova 53

Growth Factors 53

Bioventus 53

Cerapedics 54

CGBio 54

Isto 55

Medtronic 55

NuVasive 57

Wright 57

Others 58

Hyaluronic Acid Viscosupplementation 59

Anika Therapeutics 59

Bioventus 60

Cairo University 61

Ferring Pharmaceuticals 61

Federal University of Minas Gerais 62

Fidia Pharma USA Inc. 62

Istituto Ortopedico Rizzoli 63

University Hospital 63

Universidade Nova de Lisboa 64

SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 65

  • 3.1 INTRODUCTION 65

Bone Graft Substitutes 65

Growth Factors 65

Hyaluronic Acid (HA) Viscosupplementation 66

  • 3.2 CURRENCY EXCHANGE RATE 67
  • 3.3 MARKET OVERVIEW AND TREND ANALYSIS 68
  • 3.4 DRIVERS AND LIMITERS 75

Market Drivers 75

Market Limiters 75

  • 3.5 COMPETITIVE MARKET SHARE ANALYSIS 77
  • 3.6 MERGERS AND ACQUISITIONS 82
  • 3.7 COMPANY PROFILES 84

Anika Therapeutics 84

Bioventus 85

DePuy Synthes 86

Ferring Pharmaceuticals 87

Fidia Pharmaceuticals 88

Genzyme (Sanofi Group) 89

Harvest Technologies (Terumo BCT) 90

Integra LifeSciences 91

Medtronic 92

Musculoskeletal Transplant Foundation (MTF) 94

NuVasive 95

Orthofix 96

RTI Surgical 97

Stryker 98

Vericel Corporation (formerly Aastrom Bioscience) 99

Zimmer Biomet 100

  • 3.8 SWOT ANALYSIS 102

Anika Therapeutics 102

Bioventus 104

DePuy Synthes 106

Ferring Pharmaceuticals 107

Fidia Pharmaceuticals 108

Harvest Technologies (Terumo BCT) 110

Integra LifeSciences 111

Medtronic 112

Musculoskeletal Transplant Foundation (MTF) 113

NuVasive 114

Orthofix 115

Stryker 117

Vericel Corporation (formerly Aastrom Bioscience) 118

Zimmer Biomet 119

PROCEDURE NUMBERS 121

  • 4.1 INTRODUCTION 121
  • 4.2 PROCEDURES 122

Orthopedic Biomaterial Procedures by Segment 122

Orthopedic Bone Grafting Procedures 124

Units per Procedure by Indication 124

Orthopedic Bone Grafting Procedures by Material 125

Autograft Procedures by Indication 127

Allograft Procedures by Indication 130

DBM Procedures by Indication 133

Synthetic Procedures by Indication 136

Orthopedic Bone Grafting Procedures by Indication 139

Hyaluronic Acid Viscosupplementation Procedures 142

Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle 142

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 144

  • 5.1 INTRODUCTION 144
  • 5.2 MARKET OVERVIEW 145

Orthopedic Bone Graft Substitute Market by Material 145

Orthopedic Bone Graft Substitute Market by Indication 150

  • 5.3 MARKET ANALYSIS AND FORECAST 156

Total Orthopedic Bone Graft Substitute Market 156

Orthopedic Bone Graft Substitute Market by Material 158

Allograft Bone Graft Substitute Market 158

Allograft Bone Graft Substitute Market by Indication 161

Demineralized Bone Matrix Allograft Bone Graft Substitute Market 175

Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication 178

Synthetic Bone Graft Substitute Market 192

Synthetic Bone Graft Substitute Market by Indication 195

Orthopedic Bone Graft Substitute Market by Indication 209

Spine Bone Graft Substitute Market 209

Cervical Spine Bone Graft Substitute Market 212

Thoracolumbar Spine Bone Graft Substitute Market 214

Trauma Bone Graft Substitute Market 216

Non-Union Trauma Bone Graft Substitute Market 219

Fresh Fracture Trauma Bone Graft Substitute Market 221

Large Joint Reconstruction Bone Graft Substitute Market 223

Hip Reconstruction Bone Graft Substitute Market 226

Knee Reconstruction Bone Graft Substitute Market 228

Foot Reconstruction Bone Graft Substitute Market 230

Craniomaxillofacial Bone Graft Substitute Market 233

Oncology Bone Graft Substitute Market 236

  • 5.4 DRIVERS AND LIMITERS 239

Market Drivers 239

Market Limiters 239

  • 5.5 COMPETITIVE MARKET SHARE ANALYSIS 241

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 245

  • 6.1 INTRODUCTION 245

Benefits of Viscosupplementation 246

Synovial Fluid 246

  • 6.2 MARKET OVERVIEW 247
  • 6.3 MARKET ANALYSIS AND FORECAST 253

Total Hyaluronic Acid Viscosupplementation Market 253

Single-Injection Hyaluronic Acid Viscosupplementation Market 256

Three-Injection Hyaluronic Acid Viscosupplementation Market 259

Five-Injection Hyaluronic Acid Viscosupplementation Market 262

  • 6.4 DRIVERS AND LIMITERS 265

Market Drivers 265

Market Limiters 265

  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS 267

APPENDIX: ORTHOPEDIC GROWTH FACTOR MARKET 271

  • 7.1 INTRODUCTION 271

BMP-2 (Cellumed, CG Bio) 272

ABBREVIATIONS 273

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, South Korea, 2016 - 2026 2
  • Chart 1 2: Orthopedic Biomaterials Market Overview, South Korea, 2019 & 2026 2
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, South Korea, 2016 - 2026 70
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, South Korea, 2019 71
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, South Korea, 2026 72
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, South Korea, 2017 - 2026 74
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, South Korea, 2019 81
  • Chart 4 1: Orthopedic Biomaterials Market by Segment, South Korea, 2016 - 2026 123
  • Chart 4 2: Orthopedic Bone Grafting Procedures by Material, South Korea, 2016 - 2026 126
  • Chart 4 3: Autograft Procedures by Indication, South Korea, 2016 - 2026 129
  • Chart 4 4: Allograft Procedures by Indication, South Korea, 2016 - 2026 132
  • Chart 4 5: DBM Procedures by Indication, South Korea, 2016 - 2026 135
  • Chart 4 6: Synthetic Procedures by Indication, South Korea, 2016 - 2026 138
  • Chart 4 7: Orthopedic Bone Grafting Procedures by Indication, South Korea, 2016 - 2026 141
  • Chart 4 8: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, South Korea, 2016 - 2026 143
  • Chart 5 1: Orthopedic Bone Graft Substitute Market by Material, South Korea, 2016 - 2026 147
  • Chart 5 2: Orthopedic Bone Graft Substitute Market Breakdown by Material, South Korea, 2019 148
  • Chart 5 3: Orthopedic Bone Graft Substitute Market Breakdown by Material, South Korea, 2026 149
  • Chart 5 4: Orthopedic Bone Graft Substitute Market by Indication, South Korea, 2016 - 2026 153
  • Chart 5 5: Orthopedic Bone Graft Substitute Market Breakdown by Indication, South Korea, 2019 154
  • Chart 5 6: Orthopedic Bone Graft Substitute Market Breakdown by Indication, South Korea, 2026 155
  • Chart 5 7: Total Orthopedic Bone Graft Substitute Market, South Korea, 2016 - 2026 157
  • Chart 5 8: Allograft Bone Graft Substitute Market, South Korea, 2016 - 2026 160
  • Chart 5 9: Allograft Bone Graft Substitute Market by Indication, South Korea, 2016 - 2026 162
  • Chart 5 10: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, South Korea, 2016 - 2026 177
  • Chart 5 11: Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication, South Korea, 2016 - 2026 179
  • Chart 5 12: Synthetic Bone Graft Substitute Market, South Korea, 2016 - 2026 194
  • Chart 5 13: Synthetic Bone Graft Substitute Market by Indication, South Korea, 2016 - 2026 196
  • Chart 5 14: Spine Bone Graft Substitute Market, South Korea, 2016 - 2026 211
  • Chart 5 15: Cervical Spine Bone Graft Substitute Market, South Korea, 2016 - 2026 213
  • Chart 5 16: Thoracolumbar Spine Bone Graft Substitute Market, South Korea, 2016 - 2026 215
  • Chart 5 17: Trauma Bone Graft Substitute Market, South Korea, 2016 - 2026 218
  • Chart 5 18: Non-Union Trauma Bone Graft Substitute Market, South Korea, 2016 - 2026 220
  • Chart 5 19: Fresh Fracture Trauma Bone Graft Substitute Market, South Korea, 2016 - 2026 222
  • Chart 5 20: Large Joint Reconstruction Bone Graft Substitute Market, South Korea, 2016 - 2026 225
  • Chart 5 21: Hip Reconstruction Bone Graft Substitute Market, South Korea, 2016 - 2026 227
  • Chart 5 22: Knee Reconstruction Bone Graft Substitute Market, South Korea, 2016 - 2026 229
  • Chart 5 23: Foot Reconstruction Bone Graft Substitute Market, South Korea, 2016 - 2026 232
  • Chart 5 24: Craniomaxillofacial Bone Graft Substitute Market, South Korea, 2016 - 2026 235
  • Chart 5 25: Oncology Bone Graft Substitute Market, South Korea, 2016 - 2026 238
  • Chart 5 26: Leading Competitors, Orthopedic Bone Graft Substitute Market, South Korea, 2019 244
  • Chart 6 1: Hyaluronic Acid Viscosupplementation Market by Segment, South Korea, 2016 - 2026 250
  • Chart 6 2: Hyaluronic Acid Viscosupplementation Market Breakdown, South Korea, 2019 251
  • Chart 6 3: Hyaluronic Acid Viscosupplementation Market Breakdown, South Korea, 2026 252
  • Chart 6 4: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 255
  • Chart 6 5: Single-Injection Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 258
  • Chart 6 6: Three-Injection Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 261
  • Chart 6 7: Five-Injection Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 264
  • Chart 6 8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2019 270

LIST OF FIGURES

  • Figure 5 58: Craniomaxillofacial Bone Graft Substitute Market, South Korea, 2016 - 2026 234
  • Figure 5 59: Oncology Bone Graft Substitute Market, South Korea, 2016 - 2026 237
  • Figure 5 60: Drivers and Limiters, Orthopedic Bone Graft Substitute Market, South Korea, 2019 240
  • Figure 5 61: Leading Competitors, Orthopedic Bone Graft Substitute Market, South Korea, 2019 243
  • Figure 6 1: Hyaluronic Acid Viscosupplementation Market by Segment, South Korea, 2016 - 2026 (US$M) 248
  • Figure 6 2: Hyaluronic Acid Viscosupplementation Market by Segment, South Korea, 2016 - 2026 (KRWM) 249
  • Figure 6 3: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 254
  • Figure 6 4: Single-Injection Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 257
  • Figure 6 5: Three-Injection Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 260
  • Figure 6 6: Five-Injection Hyaluronic Acid Viscosupplementation Market, South Korea, 2016 - 2026 263
  • Figure 6 7: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, South Korea, 2019 266
  • Figure 6 8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2019 269